Phase 1 trial for EBC-129 progresses into dose expansion

FHS
May 24, 2024
4:32 pm

The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, is pleased to announce that the Phase 1 trial for EBC-129 has progressed into dose expansion.

Opinion | I Managed Wildfire Response for a Health System. Here’s What I Learned.

Mary Meyer MD, MPH, is an emergency physician with The Permanente Medical Group. She also holds a Master of Public Health and certificates in Global

January 11, 2025

Patients With Narcolepsy Face Mood and Pain Disorders

NASHVILLE, Tenn. — People with narcolepsy frequently had mood and pain comorbidities that complicated diagnosis and treatment plans, observational data showed. In a propensity-matched cohort

September 12, 2023

More Women Ending Pregnancies on Their Own, Some With Unsafe Methods

A growing number of women said they’ve tried to end their pregnancies on their own by doing things like taking herbs, drinking alcohol, or even

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.